Zimmer Holdings, Inc. Announces New Transfer Agent

WARSAW, Ind., Aug. 23, 2012 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, today announced that effective Friday, August 24, 2012, American Stock Transfer & Trust Company, LLC will replace Computershare/BNY Mellon Shareowner Services as the Company's transfer agent, registrar and dividend disbursing agent for its common stock.  From that date forward, all inquiries and correspondence relating to stockholder records, transfer of shares, lost certificates, dividend checks or change of address should be directed to American Stock Transfer & Trust Company, LLC.



            Mailing address:

Zimmer Holdings, Inc.


c/o American Stock Transfer & Trust Company, LLC


6201 15th Avenue


Brooklyn, NY 11219



            Telephone inquiries:

888-552-8493


718-921-8124



            Email address:

[email protected]



            Website:

http://www.amstock.com



About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.  Zimmer's 2011 sales were approximately $4.5 billion.  The Company is supported by the efforts of more than 8,500 employees worldwide.

SOURCE Zimmer Holdings, Inc.

Suggested Articles

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.

After Clovis’ Rubraca snagged an FDA boost in prostate cancer last week, AZ and Merck’s rival Lynparza has matched it with a boost of its own.